- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expression of the luteinizing hormone receptor (LHR) in ovarian cancer ; volume:19 ; number:1 ; day:15 ; month:11 ; year:2019 ; pages:1-8 ; date:12.2019
BMC cancer ; 19, Heft 1 (15.11.2019), 1-8, 12.2019
- Creator
-
Xiong, Shigang
Mhawech-Fauceglia, Paulette
Tsao-Wei, Denice
Roman, Lynda
Gaur, Rajesh K.
Epstein, Alan L.
Pinski, Jacek
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6153-8
- URN
-
urn:nbn:de:101:1-2020031401080217179837
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xiong, Shigang
- Mhawech-Fauceglia, Paulette
- Tsao-Wei, Denice
- Roman, Lynda
- Gaur, Rajesh K.
- Epstein, Alan L.
- Pinski, Jacek
- SpringerLink (Online service)
Other Objects (12)
Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
Subcellular distribution of thyroid hormone receptor beta in ovarian cancer
Sex hormones and immune regulation in ovarian cancer
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer
CD133 antigen expression in ovarian cancer
Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
Subcellular distribution of thyroid hormone receptor beta in ovarian cancer
Sex hormones and immune regulation in ovarian cancer
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer
CD133 antigen expression in ovarian cancer
Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation
Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
Subcellular distribution of thyroid hormone receptor beta in ovarian cancer
Sex hormones and immune regulation in ovarian cancer
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer